Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

797 ARTÍCULOS , VIENDO DEL 586 AL 600

Is US residence a risk factor for Alzheimer's disease?

Høilund-Carlsen PF, Alavi A, Costa T, Neve RL, Perry G, Revheim ME, Barrio JR.

J Alzheimers Dis. 2025 Sep;107(2):496-498. doi: 10.1177/13872877251356682. Epub 2025 Sep 1.

Use of Drugs Affecting GABA(A) Receptors and the Risk of Developing Alzheimer's Disease and Dementia: a Meta-Analysis and Literature Review

Vakili K, Fathi M, Ebrahimi R, Ahmadian S, Moafi M, Ebrahimi MJ, Tafazolimoghadam A, Davoodi A, Eghbaldoost A, Eyvani K, Ghayyem H, Jashni Pour M, Kosari M, Niknejad S, Sanaye Abbasi A, Zarebidoki A, Andrew M, Trenaman S, Batool Z, Sayehmiri F, Ebrahimzadeh K.

Mol Neurobiol. 2025 Jul;62(7):9449-9468. doi: 10.1007/s12035-025-04821-9. Epub 2025 Mar 20.

Red blood cell ω-3 status and longitudinal cognition in individuals at risk of Alzheimer disease

Lázaro I, Brugulat-Serrat A, Suárez-Calvet M, Fauria K, Minguillon C, Gispert JD, Molinuevo JL, Harris WS, Sánchez-Benavides G, Grau-Rivera O, Sala-Vila A; ALFA study.

J Nutr. 2025 Dec;155(12):4514-4522. doi: 10.1016/j.tjnut.2025.09.032. Epub 2025 Sep 27.

Brexpiprazole: A Balance of Risks and Benefits

Hitt EM.

Sr Care Pharm. 2025 Mar 1;40(3):115-122. doi: 10.4140/TCP.n.2025.115.

Emerging Pharmacological Approaches for Psychosis and Agitation in Alzheimer's Disease

Imbimbo C, Cotta Ramusino M, Leone S, Mazzacane F, De Franco V, Gatti A, Perini G, Costa A.

CNS Drugs. 2025 Feb;39(2):143-160. doi: 10.1007/s40263-024-01133-9. Epub 2024 Dec 2.

Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome

Dohl J, Treadwell Z, Norris C, Head E.

Alzheimers Dement. 2025 Mar;21(3):e70034. doi: 10.1002/alz.70034.

Effect of Alzheimer's disease medications on neurocognitive outcomes in children and adolescents with autism spectrum disorder and low IQ: a scoping review

Diamandis N, van den Anker JN, Denisova K.

Transl Psychiatry. 2025 Nov 17;15(1):475. doi: 10.1038/s41398-025-03655-2.

Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers

Barroeta I, Videla L, Carmona-Iragui M, Fortea J, Rafii MS.

Alzheimers Dement. 2025 Jun;21(6):e70258. doi: 10.1002/alz.70258.

Current and Emerging Pharmacological Approaches to Agitation in Alzheimer's Disease: A Narrative Review of New and Repurposed Therapies

Smoller C, Schiller E, Yamashita K, Silverglate BD, Grossberg GT.

Drugs. 2025 Nov;85(11):1391-1411. doi: 10.1007/s40265-025-02227-4. Epub 2025 Sep 6.

A critical review of brexpiprazole oral tablets as the first drug approved to treat agitation symptoms associated with dementia due to Alzheimer's disease

Zhong K, Cummings J.

Expert Rev Neurother. 2025 Jan;25(1):5-13. doi: 10.1080/14737175.2024.2407836. Epub 2024 Sep 29.

A US-based practitioner's guide to diagnosis, evaluation, and evidence-based treatment of agitation in Alzheimer's dementia - recommendations of an expert, multispecialty advisory panel

Grossberg GT, Sanford A, Montano CB, Porsteinsson AP, Scanland S, Worz C, McMillian S, Atri A.

Postgrad Med. 2025 Aug;137(6):469-485. doi: 10.1080/00325481.2025.2517535. Epub 2025 Jun 17.

Pharmacoutilization data-driven artificial intelligence-assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia

Scuteri D, Adornetto C, Greco G, Nicotera P, Bagetta G, Corasaniti MT.

Curr Opin Pharmacol. 2025 Oct;84:102563. doi: 10.1016/j.coph.2025.102563. Epub 2025 Jul 28.

Auditory Hallucinations as the First Symptom of Alzheimer´s Disease - A Case Report

Husing T, Quante A.

Curr Alzheimer Res. 2025;22(11):864-867. doi: 10.2174/0115672050421769250929051818.

Evaluating the Bidirectional Causal Effects of Alzheimer's Disease Across Multiple Conditions: A Systematic Review and Meta-Analysis of Mendelian Randomization Studies

Zhu H, Ni H, Yang Q, Ni J, Ji J, Yang S, Peng F.

Int J Mol Sci. 2025 Apr 10;26(8):3589. doi: 10.3390/ijms26083589.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias